Trending:
Analysis
-
![Incretin combination therapy: a breakthrough for type 2 diabetes?]()
Incretin combination therapy: a breakthrough for type 2 diabetes?
With unmet needs remaining in type 2 diabetes, pharmaceutical companies are becoming more experimental when developing new treatments. One trend includes combining drugs in one class to determine if they...
-
![Ebola in the DRC: vaccinating in a conflict zone]()
Ebola in the DRC: vaccinating in a conflict zone
Attempts to control the Ebola outbreak in the north-eastern Democratic Republic of Congo have been hindered by ongoing conflict in the area. While Merck’s experimental Ebola vaccine was on the...
-
![Is China the next great hope for the pharma industry?]()
Is China the next great hope for the pharma industry?
Many top pharma firms have been forced to drop prices to get a slice of the Chinese market, but that hasn’t dampened spirits one bit – on the contrary, CEOs...
-
![November’s top stories]()
November’s top stories
Sobi has signed agreements to acquire the rights to AstraZeneca’s Synagis medicine in the US for an upfront payment of $1.5bn, and Takeda Pharmaceutical has received a conditional approval from...
-
![Pat-INFORMED: the solution to drug patent procurement issues?]()
Pat-INFORMED: the solution to drug patent procurement issues?
Many countries do not have the equivalent to the US’s Orange book, meaning that health officials are wasting time establishing whether patents have been taken out on medicines. Leading biopharmaceutical...
-
![Will tech giants like Amazon and Google change the pharma sector forever?]()
Will tech giants like Amazon and Google change the pharma sector forever?
The world’s tech giants have recognised vast business opportunities in the healthcare space, and could soon threaten established drug developers and high street pharmacies. What will they have to do...
-
![Antimicrobial resistance: is pharmaceutical pollution creating superbugs?]()
Antimicrobial resistance: is pharmaceutical pollution creating superbugs?
In 2001 the European Commission identified a link between antibiotic waste and the threat of superbugs resulting from antimicrobial resistance, yet to date, no effective measures have been taken to...
-
![The Express Scripts story: super-pharmacies and the US drug industry]()
The Express Scripts story: super-pharmacies and the US drug industry
Express Scripts, the largest independent manager of pharmacy benefits in the United States, recently updated the formula it uses to decide which drugs to sell, a move that resulted in...
-
![Effective containment systems for high potency active pharmaceutical ingredients (HP APIs)]()
Effective containment systems for high potency active pharmaceutical ingredients (HP APIs)
As the use of high potency active pharmaceutical ingredients (HP APIs) becomes more common in drug manufacturing, effective engineering controls or 'containment systems' are more important than ever to assure...
-
![Pharma Technology Focus – Issue 77]()
Pharma Technology Focus – Issue 77
In this issue: China’s growing pharmaceutical market, antimicrobial resistance, the rise of tech giants in healthcare, and more.
